Cardiovascular proteomics: tools to develop novel biomarkers and potential applications.
about
The Discovery of Novel Genomic, Transcriptomic, and Proteomic Biomarkers in Cardiovascular and Peripheral Vascular Disease: The State of the ArtUsing extracellular matrix proteomics to understand left ventricular remodelingAdvances in Integrating Traditional and Omic Biomarkers When Analyzing the Effects of the Mediterranean Diet Intervention in Cardiovascular PreventionNovel methodologies for biomarker discovery in atherosclerosisTop-down quantitative proteomics identified phosphorylation of cardiac troponin I as a candidate biomarker for chronic heart failureComputational models reduce complexity and accelerate insight into cardiac signaling networksRisk communication formats for low probability events: an exploratory study of patient preferences.Cardiovascular proteomics: implications for clinical applicationsLeft ventricular hypertrophy induced by abdominal aortic banding and its prevention by angiotensin receptor blocker telmisartan--a proteomic analysis.Systems biology in heart diseases.Pathway analysis of dilated cardiomyopathy using global proteomic profiling and enrichment maps.The platelet proteome.Proteomics and mass spectrometry: what have we learned about the heart?Proteomic analysis of circulating human monocytes in coronary artery disease.Quantitative proteomics in cardiovascular research: global and targeted strategiesHow well do commonly used data presentation formats support comparative effectiveness evaluations?Peptidomic profiles of post myocardial infarction rats affinity depleted plasma using matrix-assisted laser desorption/ionization time of flight (MALDI-ToF) mass spectrometry.Molecular targets for anti-oxidative protection of green tea polyphenols against myocardial ischemic injury.ATP-sensitive K(+) channel-deficient dilated cardiomyopathy proteome remodeled by embryonic stem cell therapy.Plasma proteome changes in cardiovascular disease patients: novel isoforms of apolipoprotein A1.Brain derived neurotrophic factor contributes to the cardiogenic potential of adult resident progenitor cells in failing murine heart.Proteomic analysis of age dependent nitration of rat cardiac proteins by solution isoelectric focusing coupled to nanoHPLC tandem mass spectrometry.Cardioproteomics: advancing the discovery of signaling mechanisms involved in cardiovascular diseasesComprehensive analysis of protein modifications by top-down mass spectrometryThe use of urinary proteomics in the assessment of suitability of mouse models for ageing.Systems proteomics for translational network medicine.Identification of ageing-associated naturally occurring peptides in human urineProteomics in atherothrombosis: a future perspective.Predict, prevent and personalize: Genomic and proteomic approaches to cardiovascular medicineRecent advances in cardiovascular proteomics.Biomarker discovery: proteome fractionation and separation in biological samples.PGC-1alpha and ERRalpha target gene downregulation is a signature of the failing human heart.Proteomic Biomarkers of Atherosclerosis.Biochemical markers of myocardial remodelling in hypertensive heart disease.Recent advances in atherosclerosis-based proteomics: new biomarkers and a future perspective.Update on integrated biomarkers for assessment of long-term risk of cardiovascular complications in initially healthy subjects and patients with manifest atherosclerosis.Multi-marker strategies in heart failure: clinical and statistical approachesChallenges and standards in reporting diagnostic and prognostic biomarker studies.The cardiovascular continuum refined: A hypothesis.Recent advances in the use of Sus scrofa (pig) as a model system for proteomic studies.
P2860
Q26746121-539D647B-DB3E-45C5-9BD4-EB2AB1468349Q26863127-D7B7BACD-174B-4DE1-8EE0-EC903DC54E52Q28069172-3A921FF1-84D9-413F-964E-B7537324153FQ28088373-A7A54D90-6942-43F0-A3A9-A58F98DEB568Q28243166-18B3E675-DD9E-48EE-AD5E-CFEE9FC15CCDQ30428985-EFBA2234-6870-4F55-B56E-8B3AD45F7CF0Q33327577-99EAF2C5-8476-4DE6-A8EA-FB30737F11D2Q33579184-3AA881EC-5E3E-41C7-8A94-EA39B6F7807BQ33653362-631FB323-F7CF-404D-9825-37463173B556Q33745563-243C5310-9240-42C4-9A8F-050C005EC410Q33887660-FB68FD69-F3D1-49DD-AA12-F8E7ABA5A2B0Q33904184-D5CC3BA1-61EB-4406-A54E-3B93581A5E88Q33940880-78635889-4798-41F5-8620-04F82609C8C2Q34027425-20911C9D-2420-4417-B414-125405C302BEQ34156082-ED9A68B3-0FD4-4EE6-A1DA-1BDE702EF006Q34278607-DD355CB9-37B3-4459-9D7A-4EFBEAEA552AQ34570057-F4E610F3-672E-438D-82B1-829C1A969960Q34691630-4646E15E-5E12-4B45-B523-1359AF0136A6Q35087287-BE0AF7CC-CC75-436A-85AA-649784D20548Q35574360-0AEBF2EC-B724-458B-97E3-24A12CA368C5Q35584104-EBCDAB7A-18EA-421D-84C4-F8D020EBE9F2Q35608301-238E4469-1C15-48DA-8A4A-EB6CA3E265C2Q35660191-A9B87E42-DC91-4767-BB99-45E35D643DE4Q35873932-A7782F6F-5FA7-457D-A29E-4FAF5EE9D589Q36281053-17C0E752-B152-47A1-A869-13E1237858A2Q36303108-079014D9-0578-48D0-BBBC-640DA36B3A6CQ36544030-75513E5F-CC98-4C60-9107-BF9F2617FEC7Q36787244-8961DFC2-E31A-47E1-BD07-741AD29FD498Q36898747-E3CBA7C2-3D12-4956-8CD9-7DD45A776C2EQ37000977-30657765-EE0D-49A0-BEB3-5633CF8EBA39Q37046315-310A016F-6AC2-41B7-8B32-44C50BCFB66DQ37189947-87B58485-35A1-43F4-BF32-1FEAD3215D46Q37207340-031C9F32-FDAD-4D52-8E04-2A7358EE544CQ37258076-38D93AD1-3182-4960-B0D2-B3DE88981764Q37304123-9A9AAEA5-D3F5-4D27-B42C-14073EEEB54EQ37416508-6654DEE6-3D22-4A6F-8AE7-575FDC0D4592Q37468671-89D17F2B-D886-4A48-9147-1FEE5BACA969Q37700366-11F36B4D-690D-45C7-8D97-F25610B2A1C9Q37743531-7BFCF802-7DE3-4761-B6B7-E5AD3084666CQ37828115-EADA1E45-3C8A-44D2-99A1-D13E426E5970
P2860
Cardiovascular proteomics: tools to develop novel biomarkers and potential applications.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Cardiovascular proteomics: tools to develop novel biomarkers and potential applications.
@ast
Cardiovascular proteomics: tools to develop novel biomarkers and potential applications.
@en
type
label
Cardiovascular proteomics: tools to develop novel biomarkers and potential applications.
@ast
Cardiovascular proteomics: tools to develop novel biomarkers and potential applications.
@en
prefLabel
Cardiovascular proteomics: tools to develop novel biomarkers and potential applications.
@ast
Cardiovascular proteomics: tools to develop novel biomarkers and potential applications.
@en
P2093
P50
P1476
Cardiovascular proteomics: tools to develop novel biomarkers and potential applications.
@en
P2093
Anthony O Gramolini
Brian Stanley
David H MacLennan
Jennifer van Eyk
Maral Ouzounian
Peter P Liu
P304
P356
10.1016/J.JACC.2006.06.063
P407
P577
2006-10-17T00:00:00Z